Top Companies and Their Offerings
What are the Recent Developments in the Market?
- In March 2026, an integrated, real-time monitoring platform, connected to the health ecosystem Tracky, was launched by DrStore Healthcare Services for tracking GLP-1 therapy outcomes. The platform integrates data from continuous glucose monitoring, activity levels, body composition tracking, wearable devices, and food and calorie logs, enabling clinicians and pharmaceutical companies to monitor patient health, therapy effectiveness, and improve patient management.
- In March 2026, two innovative continuous glucose monitoring devices, that is, Diasens™ and GlucoLive™, integrating AI-powered analytics with comprehensive remote care capabilities, were launched by Zydus Lifesciences Limited. These devices will help to overcome the critical challenge in India, hosting over 101 million adults with diabetes and 136 million individuals in the pre-diabetic stage, as per the ICMR-INDIAB study.
Market Analysis
| Ecosystem Segment | Description | Key Participants |
| Technology Providers | Develop sensing technologies, biosensors, transmitters, mobile connectivity, cloud analytics, and AI-enabled glucose monitoring solutions | Abbott, Dexcom, Medtronic, Senseonics, Nemaura Medical |
| Product Manufacturers | Design and manufacture CGM sensors, transmitters, receivers, and integrated diabetes management systems | Abbott, Dexcom, Medtronic, Roche Diagnostics, Senseonics |
| Digital Health & Platform Providers | Offer CGM-enabled metabolic health programs, coaching platforms, data analytics, and remote monitoring services | Ultrahuman, HealthifyMe, Sugar.fit, BeatO, Ambrosia Systems |
| Software & Analytics Vendors | Provide cloud-based glucose analytics, reporting dashboards, patient engagement tools, and clinician decision-support platforms | Dexcom Clarity, LibreView (Abbott), Medtronic CareLink, Ambrosia Systems |
| Distribution & Commercialization Partners | Handle market access, physician engagement, sales, regulatory compliance, and channel distribution in India | Abbott India, Medtronic India, Roche Diabetes Care India, Ascensia Diabetes Care |
| Healthcare Service Providers | Utilize CGM devices for diabetes diagnosis, treatment optimization, and patient monitoring | Hospitals, Endocrinology Clinics, Diabetes Centers, Telehealth Providers |
| Research & Clinical Institutions | Conduct CGM clinical studies, diabetes research, validation studies, and digital health evaluations | Indian Council of Medical Research, All India Institute of Medical Sciences, Madras Diabetes Research Foundation |
| End Users | Individuals and organizations using CGM systems for diabetes and metabolic health management | Type 1 Diabetes Patients, Type 2 Diabetes Patients, Prediabetic Individuals, Healthcare Providers, Corporate Wellness Programs |
| Regulatory & Standards Bodies | Oversee device approvals, quality standards, and market access | Central Drugs Standard Control Organization, Bureau of Indian Standards |
Market Value Chain Analysis
R&D
- The R&D of India continuous glucose monitoring devices focuses on the development of ultra-thin, non-invasive optical sensors, AI-driven metabolic analytics platforms, and extended-wear sensors.
- Key players: Abbott Laboratories, Dexcom, Inc., and Medtronic plc.
Clinical Trials and Regulatory Approvals
- Sensor measurement accuracy, signal stability, and skin biocompatibility are evaluated in the clinical trials and regulatory approvals of the continuous glucose monitoring devices in India.
- Key players: Abbott Laboratories, Dexcom, Inc., and Medtronic plc.
Patient Support and Services
- Personalized digital onboarding sessions, subscription-based dietetic coaching, and dedicated WhatsApp tech support hotlines are provided in the patient support and services of the continuous glucose monitoring devices in India.
- Key players: Abbott Laboratories, Dexcom, Inc., and Medtronic plc.
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to CGM |
| Abbott Laboratories | Abbott Park, Illinois | USA | Clear market leader in India CGM market with extensive physician adoption, strong distribution network, and significant penetration through Libre systems | FreeStyle Libre, FreeStyle Libre 2, LibreView |
| Dexcom | San Diego, California | USA | Global leader in real-time CGM technology with growing adoption among insulin-dependent diabetes patients and digital health users in India | Dexcom G7, Dexcom ONE+, Dexcom Clarity |
| Medtronic plc | Galway | Ireland | Major player in advanced diabetes management with integrated CGM and automated insulin delivery systems | Guardian 4 Sensor, MiniMed 780G System |
| Roche Diagnostics | Rotkreuz, Zug | Switzerland | Established diabetes monitoring company leveraging its diabetes care ecosystem and physician relationships to expand CGM offerings | Accu-Chek Smart CGM Solutions, Digital Diabetes Platforms |
| Ascensia Diabetes Care | Basel | Switzerland | Commercialization partner for implantable CGM technologies and an established diabetes management company with expanding CGM presence | Eversense CGM (via Senseonics partnership), Diabetes Management Solutions |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Senseonics Holdings | Germantown, Maryland | USA | Pioneer in long-duration implantable CGM systems | Eversense CGM |
| Ultrahuman Healthcare Pvt. Ltd. | Bengaluru, Karnataka | India | Major metabolic health platform utilizing CGM technology | Ultrahuman M1 |
| HealthifyMe Wellness Pvt. Ltd. | Bengaluru, Karnataka | India | Integrates CGM into digital metabolic health programs | Healthify CGM Programs |
| Sugar.fit | Bengaluru, Karnataka | India | Large diabetes care platform using CGM-based coaching | CGM-enabled Diabetes Reversal Programs |
| BeatO (Health Arx Technologies) | New Delhi, Delhi | India | Expanding CGM-supported diabetes management ecosystem | BeatO CGM Services |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| DrStore Healthcare Services India Pvt. Ltd. (Tracky) | Gurugram, Haryana | India | Launched India's Bluetooth-enabled CGM offering | Tracky CGM |
| Actofit Tech Pvt. Ltd. | Mumbai, Maharashtra | India | Expanding preventive-health CGM applications | Actofit CGM Programs |
| Nemaura Medical, Inc. | Loughborough | United Kingdom | Developer of non-invasive glucose monitoring technologies | SugarBEAT |
| GlucoRx Ltd. | Surrey, England | United Kingdom | Technology provider supporting newer CGM solutions entering India | GlucoRx CGM Systems |
| Ambrosia Systems Inc. | San Jose, California | USA | Provides CGM analytics and monitoring services increasingly used in India | NightRider, CGM Analytics |
Market Growth
The India continuous glucose monitoring devices market size stood at US$ 165 million in 2025, grew to US$ 189.42 million in 2026, and is forecast to reach US$ 656 million by 2035, expanding at a CAGR of 14.8% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking